These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6838072)

  • 1. Anomalous serum digoxin concentrations in uremia.
    Craver JL; Valdes R
    Ann Intern Med; 1983 Apr; 98(4):483-4. PubMed ID: 6838072
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
    Dasgupta A; Trejo O
    Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous serum concentrations of digoxin.
    Rolan PE; Frewin DB; Hagley SR
    Ann Intern Med; 1983 Aug; 99(2):280-1. PubMed ID: 6881792
    [No Abstract]   [Full Text] [Related]  

  • 4. False-positive digoxin measurements due to conjugated metabolite accumulation in combined renal and hepatic dysfunction.
    Vlasses PH; Besarab A; Lottes SR; Conner DP; Green PJ; Gault MH
    Am J Nephrol; 1987; 7(5):355-9. PubMed ID: 3324762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed digoxin toxicity following discontinuance in acute renal failure.
    Ho AM; Fraser IM; Suria DD
    Can J Anaesth; 1987 Mar; 34(2):178-81. PubMed ID: 3829306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endogenous digoxin-like substance and renal failure.
    Heazlewood VJ; Heazlewood RL; Jellett LB
    Ann Intern Med; 1984 Apr; 100(4):618. PubMed ID: 6703564
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin-like immunoreacting substance(s) in the serum of patients with chronic uremia.
    Kramer HJ; Pennig J; Klingmüller D; Kipnowski J; Glänzer K; Düsing R
    Nephron; 1985; 40(3):297-302. PubMed ID: 4010843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin-like substance in the serum of uremic patients before and after hemodialysis.
    Durakovic Z; Ivanovic D; Durakovic A
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):757-60. PubMed ID: 2488089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations.
    Wu SL; Li W; Wells A; Dasgupta A
    Am J Clin Pathol; 2001 Apr; 115(4):600-4. PubMed ID: 11293909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferences in TDx digoxin assay in dialysis patients.
    Bianchi P
    Clin Chem; 1986 Nov; 32(11):2099. PubMed ID: 3536173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Verapamil-induced digoxin poisoning in uremia].
    Johannessen AC; Poulsen S
    Ugeskr Laeger; 1985 May; 147(19):1547-8. PubMed ID: 4012876
    [No Abstract]   [Full Text] [Related]  

  • 12. Digoxin determination in the uremic patient: three immunoassays compared.
    Oldfield PR; Singer BE; Toseland PA
    Clin Chem; 1985 Jul; 31(7):1246. PubMed ID: 4006207
    [No Abstract]   [Full Text] [Related]  

  • 13. [High levels of digoxin encountered in patients with chronic uremia undergoing a periodic hemodialytic treatment and conservative therapy].
    Filoramo F; Redaelli B; Pincella G; Sforzini S; Limido D; D'Amico P; Valagussa F
    Minerva Nefrol; 1976; 23(5):393-6. PubMed ID: 1018876
    [No Abstract]   [Full Text] [Related]  

  • 14. Anomalous serum digoxin concentrations in patients with hepatic or renal dysfunction.
    Frewin DB; Marmanidis H; Lehmann DR; Morris RG
    Aust N Z J Med; 1986 Apr; 16(2):241-3. PubMed ID: 3463280
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
    Reyes MA; Actor JK; Risin SA; Dasgupta A
    Ther Drug Monit; 2008 Feb; 30(1):95-9. PubMed ID: 18223469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected suppression of total digoxin concentrations by cross-reactants in the microparticle enzyme immunoassay: elimination of interference by monitoring free digoxin concentration.
    Dasgupta A; Scott J
    Am J Clin Pathol; 1998 Jul; 110(1):78-82. PubMed ID: 9661925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A; Tso G; Wells A
    Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
    Embree L; McErlane KM
    Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies in digoxin results between two fluorescence immunoassays.
    Fleming JJ
    Clin Chem; 1986 Jul; 32(7):1411-2. PubMed ID: 3521948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.